Spelling suggestions: "subject:"fanconi anaemia"" "subject:"zanconi anaemia""
1 |
The Fanconi Anaemia Protein FANCJ is Involved in the Alternative Lengthening of Telomeres (ALT) Mechanism in Human CellsKomosa, Martin 25 August 2011 (has links)
Approximately 15% of human cancers utilize a recombination-based mechanism termed Alternative Lengthening of Telomeres (ALT) to maintain the lengths of their telomeres. The Fanconi anaemia protein FANCJ localizes to telomeric foci in human ALT cells, but not in telomerase-positive or primary cells. Telomere-associated FANCJ frequently localizes with FANCD2 and BRCA1, and primarily localizes to ALT-associated PML nuclear bodies. Depletion of FANCJ in human ALT cells causes the loss of BRCA1 at telomeric foci and a decrease in telomeric repeat DNA content primarily as a result of the loss of the brightest telomeric repeat DNA foci. In contrast, depletion of the FANCD2 results in increased telomeric repeat DNA synthesis and this is suppressed upon the codepletion of FANCJ. Together, data from this study suggest that FANCJ is required for telomeric repeat DNA synthesis in human ALT cells, which may or may not be dependent on BRCA1, and FANCD2 restrains this synthesis.
|
2 |
The Fanconi Anaemia Protein FANCJ is Involved in the Alternative Lengthening of Telomeres (ALT) Mechanism in Human CellsKomosa, Martin 25 August 2011 (has links)
Approximately 15% of human cancers utilize a recombination-based mechanism termed Alternative Lengthening of Telomeres (ALT) to maintain the lengths of their telomeres. The Fanconi anaemia protein FANCJ localizes to telomeric foci in human ALT cells, but not in telomerase-positive or primary cells. Telomere-associated FANCJ frequently localizes with FANCD2 and BRCA1, and primarily localizes to ALT-associated PML nuclear bodies. Depletion of FANCJ in human ALT cells causes the loss of BRCA1 at telomeric foci and a decrease in telomeric repeat DNA content primarily as a result of the loss of the brightest telomeric repeat DNA foci. In contrast, depletion of the FANCD2 results in increased telomeric repeat DNA synthesis and this is suppressed upon the codepletion of FANCJ. Together, data from this study suggest that FANCJ is required for telomeric repeat DNA synthesis in human ALT cells, which may or may not be dependent on BRCA1, and FANCD2 restrains this synthesis.
|
3 |
Investigations into the role of EVI1 in Fanconi Anaemia associated leukaemic TransformationSchneider, Marion January 2016 (has links)
The inherited bone marrow failure syndrome Fanconi Anaemia (FA) is caused by mutations in any one of the multiple FANC genes, which encode proteins that collaborate in the FA/BRCA DNA damage response pathway. FA is characterised by extreme predisposition to acute myeloid leukaemia (AML). AML in FA is associated with typical chromosomal aberrations involving gains of the long arm of chromosome 3 (3q gains). These are linked to overexpression of the oncogene ecotropic viral integration site 1 (EVI1). Based on this clinical observation, the hypothesis that EVI1 confers leukaemic transformation, in particular in the context of FA, was tested. Mouse embryonic stem cells with either functional or disrupted FA/BRCA-pathway were used to model normal and FA-associated embryonic haematopoiesis, and the effect of EVI1 overexpression was assessed in this model. EVI1 functions were also investigated with respect to protein interactions, focusing on the interaction with the co-repressor C-terminal binding protein 1 (CtBP1), in the context of genotoxic stress. To study this, in vitro haematopoietic differentiation assays, flow cytometry, mass spectrometry, immunoprecipitations and immunofluorescence were employed. In vitro haematopoietic differentiation using mouse embryonic stem cells with defective Fanca was successfully developed and applied. The analysis revealed that EVI1 overexpression in haemangioblast-like cells prevented the generation of haematopoietic precursors through endothelial to haematopoietic transition. Studies into EVI1 protein interaction dynamics showed that DNA damage-induced phosphorylation of EVI1 modifies interaction with the co-repressor CtBP1. This interaction was demonstrated to be partially required for the EVI1-induced block of the development of haematopoietic precursors using the mESC-based model. An EVI1-mediated modulation of the FA phenotype characteristic G2-arrest and of the FA-associated embryonic haematopoiesis was not demonstrated. This study contributes to the understanding of the function of the EVI1 oncogene in normal and FA-associated haematopoiesis and the DNA damage response. FA-associated haematopoiesis and leukaemogenesis can be further studied using the embryonic haematopoiesis model developed here, and further studies can build on the data generated with respect to EVI1.
|
4 |
The Fanconi Anaemia Protein D2 has an Essential Role in Telomere Maintenance in Cells that Utilize the Alternative Lengthening of Telomeres PathwayRoot, Heather 17 February 2011 (has links)
Fanconi anaemia (FA) is an inherited disorder characterized by bone marrow failure, cancer predisposition and congenital abnormalities. The 12 known FA genes have been implicated in homologous recombination (HR), a process involved in telomere maintenance. A complex of at least 7 FA proteins promotes FANCD2 monoubiquitination and nuclear foci formation. FANCD2 colocalizes and interacts with HR proteins, however the role of FANCD2 in HR is unclear.
Telomeres in dividing human somatic cells shorten until they reach a critical length, triggering most cells to undergo senescence or apoptosis. Rare immortal cells escape this crisis by expressing telomerase, or activating the Alternative Lengthening of Telomeres (ALT) pathway, which involves HR.
FA core complex proteins and FANCD2 colocalize with telomeric foci in ALT, but not telomerase positive cells. Localization of FANCD2 to ALT telomeric foci requires monoubiquitination by the FA core complex, but is independent of ATM and ATR.
FANCD2 primarily colocalizes with ALT telomeric DNA within ALT-associated PML bodies (APBs). Electron spectroscopic imaging and FISH experiments show that APBs contain extra-chromosomal telomeric repeat (ECTR) DNA that is non-nucleosomal. Depletion of FANCD2 causes marked increases in ECTR in ALT, but not telomerase positive cells. Overexpression of BLM, the helicase mutated in Bloom syndrome, also causes an ALT-specific increase in ECTR DNA. FANCD2 coimmunoprecipitates with BLM in ALT cells, and FANCD2 localization to ALT telomeric foci requires BLM expression.
FANCD2-depleted ALT cells have reduced viability, signs of mitotic catastrophe, and multiple types of telomeric abnormalities, including increases in telomeric recombination, entanglements, colocalization with DNA repair proteins, and expression of fragile site characteristics. SiRNA depletion of FANCD2 does not cause overexpression of BLM, however codepletion of BLM with FANCD2 suppresses the telomere phenotypes caused by FANCD2 knockdown. Together this suggests that FANCD2 regulates BLM-dependent recombination and amplification of telomeric DNA within ALT cells.
|
5 |
The Fanconi Anaemia Protein D2 has an Essential Role in Telomere Maintenance in Cells that Utilize the Alternative Lengthening of Telomeres PathwayRoot, Heather 17 February 2011 (has links)
Fanconi anaemia (FA) is an inherited disorder characterized by bone marrow failure, cancer predisposition and congenital abnormalities. The 12 known FA genes have been implicated in homologous recombination (HR), a process involved in telomere maintenance. A complex of at least 7 FA proteins promotes FANCD2 monoubiquitination and nuclear foci formation. FANCD2 colocalizes and interacts with HR proteins, however the role of FANCD2 in HR is unclear.
Telomeres in dividing human somatic cells shorten until they reach a critical length, triggering most cells to undergo senescence or apoptosis. Rare immortal cells escape this crisis by expressing telomerase, or activating the Alternative Lengthening of Telomeres (ALT) pathway, which involves HR.
FA core complex proteins and FANCD2 colocalize with telomeric foci in ALT, but not telomerase positive cells. Localization of FANCD2 to ALT telomeric foci requires monoubiquitination by the FA core complex, but is independent of ATM and ATR.
FANCD2 primarily colocalizes with ALT telomeric DNA within ALT-associated PML bodies (APBs). Electron spectroscopic imaging and FISH experiments show that APBs contain extra-chromosomal telomeric repeat (ECTR) DNA that is non-nucleosomal. Depletion of FANCD2 causes marked increases in ECTR in ALT, but not telomerase positive cells. Overexpression of BLM, the helicase mutated in Bloom syndrome, also causes an ALT-specific increase in ECTR DNA. FANCD2 coimmunoprecipitates with BLM in ALT cells, and FANCD2 localization to ALT telomeric foci requires BLM expression.
FANCD2-depleted ALT cells have reduced viability, signs of mitotic catastrophe, and multiple types of telomeric abnormalities, including increases in telomeric recombination, entanglements, colocalization with DNA repair proteins, and expression of fragile site characteristics. SiRNA depletion of FANCD2 does not cause overexpression of BLM, however codepletion of BLM with FANCD2 suppresses the telomere phenotypes caused by FANCD2 knockdown. Together this suggests that FANCD2 regulates BLM-dependent recombination and amplification of telomeric DNA within ALT cells.
|
6 |
Estudo das mutações do gene FANCG em pacientes com quadro clinico sugestivo de anemia de Fanconi / Mutation analysis of FANCG gene in patients with compatible clinical to Fanconi anaemiaAmstalden, Lucila Gobby 07 March 2006 (has links)
Orientador: Carmen Silvia Bertuzzo / Dissertação (mestrado) - Universidade Estadual de Campinas, Faculdade de Ciencias Medicas / Made available in DSpace on 2018-08-07T00:23:33Z (GMT). No. of bitstreams: 1
Amstalden_LucilaGobby_M.pdf: 4346952 bytes, checksum: 99d5f1ab2aae2aeb65d633016bc318a8 (MD5)
Previous issue date: 2006 / Resumo: A Anemia de Fanconi (AF) é uma doença caracterizada por múltiplas anomalias congênitas, progressiva falha da medula óssea e alto risco para desenvolvimento de câncer. E denominada também de Síndrome da Instabilidade Cromossômica devido ao fato de suas células apresentarem hipersensibilidade a agentes indutores de quebras cromossômicas. A mais importante das características clínicas é a manifestação hematológica. A incidência da anemia aplástíca, Síndrome Mieloplásica e Leucemia Mielóide Aguda é a maior resposável pela morbidade e mortalidade na AF A incidência da AF em todo o mundo é de. aproximadamente, 3 por milhão. No Brasil não há dados sobre a prevalência da doença. Foram descobertos 12 grupos de complementação e descobertos, até o momento. 11 genes relacionados ao distúrbio. São eles: FANCA. B, C, Dl, D2, E. F G, I, J, L e M. O trabalho teve como objetivo geral a análise das mutações principais (IVS8+2A>G, IVS11+lOC, IVS3+1G>C e 1794J803dellO) do gene FANCG em pacientes com quadro clínico compatível com AF. Foram analisados 38 indivíduos por meio da técnica de PCR associada à digestão e triagem por SSCP e subseqüente seqüenciamento. Nós encontramos um homozigoto para a mutação IVS8+2A>G e uma variante neutra (H482H). Concluímos com nosso estudo que, há uma heterogeneidade molecular em nosso meio; o DEB teste não é 100% eficaz na detecção de indivíduos com AF; o Teste de Complementação deve ser introduzido o quanto antes em nosso país para auxiliar no direcionamento da pesquisa para um determinado gene e minimizar os casos em que não há a confirmação de diagnóstico e, por último, há a necessidade de um Registro Brasileiro para AF com o objetivo de recolher informações clinicas e genéticas de indivíduos com o distúrbio. / Abstract: Fanconi anaemia (FA) is an autosomal recessive disease characterised by congenital abnormalities, progressive bone marrow failure and high risk of developing cancer. It's called Chromosomal Instability Syndrome due to the fact of cells presents hipersensibility to DNA cross-linking agents like mitomycin C and diepoxybutane. The most important clinical feature is hematologic. The incidence of aplastic anemia, myelodysplastic syndrome and acute myeloide leukaemia is the most important cause of morbidity and mortality in FA. The incidence of FA is approximately three per million and the heterozygote frequency is estimated at 1 in 300 in Europe and United States. In Brazil there's not data about prevalence of FA. It was discovered at least 12 complementation groups and eleven gene have been cloned: FANCA, B, C, DJ, D2, E, F, G, I, J, L eM. The study had as general objective the analysis of the main mutation (IVS8-2A>G, TVSll+lOC, IVS3+1G>C e 1794J803dell0) of FANCG gene in patients with clinical features of FA. It was analysed 38 patients through the test polymerase chain reaction (PCR) associated with digestion and mutation screening by SSCP with posterior sequencing. Molecular analysis found a homozygote to rVS8+2A>G and a neutral variant (H482H). We concluded that there's a molecular heterogeneity in our region; it's necessary to introduce the use of complementary tests in Brazil, in order to address the molecular analysis and at last, it's necessary a Brazilian Fanconi Anemia Registry (BFAR) to receive clinical and genetics information of AF patients. / Mestrado / Ciencias Biomedicas / Mestre em Ciências Médicas
|
7 |
The Use of Haematopoietic Stem Cell Transplantation in Fanconi anaemia Patients: A Survey of Decision Making Among Families in the US and CanadaHutson, Sadie P., Han, Paul K.J., Hamilton, Jada G., Rife, Sean C., Al-Rahawan, Mohamad M., Moser, Richard P., Duty, Seth P., Anand, Sheeba, Alter, Blanche P. 01 January 2015 (has links)
Background: Fanconi anaemia (FA) is a rare genetic disorder associated with bone marrow failure (BMF), congenital anomalies and cancer susceptibility. Stem cell transplantation (SCT) offers a potential cure for BMF or leukaemia, but incurs substantial risks. Little is known about factors influencing SCT decision making. Objective: The study objective was to explore factors influencing patients' with FA and family members' decision making about SCT. Design: Using a mixed-methods exploratory design, we surveyed US and Canadian patients with FA and family members who were offered SCT. Main variables studied: Closed-ended survey items measured respondents' beliefs about the necessity, risks and concerns regarding SCT; multivariable logistic regression was used to examine the association between these factors and the decision to undergo SCT. Open-ended survey items measured respondents' perceptions of factors important to the SCT decision; qualitative analysis was used to identify emergent themes. Results: The decision to undergo SCT was significantly associated with greater perceived necessity (OR = 2.81, P = 0.004) and lower concern about harms of SCT (OR = 0.31, P = 0.03). Qualitative analysis revealed a perceived lack of choice among respondents regarding the use of SCT, which was related to physician influence and respondent concerns about patients' quality of life. Conclusions: Overall, study results emphasize the importance of the delicate interplay between provider recommendation of a medical procedure and patient/parental perceptions and decision making. Findings can help providers understand the need to acknowledge family members' perceptions of SCT decision making and offer a comprehensive discussion of the necessity, risks, benefits and potential outcomes.
|
8 |
Studium regulace a funkce DNA-opravných enzymů UBE2T a FANCL / Study of regulation and function of DNA repair enzymes UBE2T and FANCLHušková, Andrea January 2019 (has links)
Due to the action of endogenous and exogenous agents, DNA is subject up to 70,000 lesions per day, thus the existence of repair mechanisms and enzymes is more than necessary. We know basic mechanisms of several specific DNA repair pathways, of which the Fanconi anaemia (FA) repair pathway is one of the least explored. FA is a rare, autosomal recessive disorder characterized by early onset bone marrow failure, developmental defects, genomic instability and predisposition to acute myeloid leukaemia and solid tumours. The primary diagnosis of FA is a hypersensitivity to cross-linking agents of DNA due to inactivation of one of the 21 genes from the FA repair pathway, the so-called FANC genes (FA complementation group). The molecular defect in FA is an impaired repair of DNA interstrand cross-links (ICLs). The ICLs are cytotoxic lesions that inhibit the process of DNA replication and transcription. A crucial step in the FA pathway that initiates ICL repair is a monoubiquitination of FANCD2. FANCD2 monoubiquitination is a base for the recruitment of additional proteins that coordinate DNA repair. Ubiquitin is recruited via activating enzyme E1 (UBA1), ubiquitin-conjugating enzyme E2T (UBE2T) and transferred onto FANCD2 by multisubunit E3 ligase (FA core complex). There are up to 11 different proteins...
|
9 |
Loss of rad51 in zebrafish (Danio rerio) : a novel Fanconi anaemia modelBotthof, Jan Gregor January 2017 (has links)
RAD51 is an indispensable homologous recombination protein, necessary for strand invasion and crossing over. It has recently been designated as a Fanconi anaemia (FA) gene, following the discovery of two patients carrying dominant negative mutations. FA is a hereditary DNA repair disorder characterised by various congenital abnormalities, progressive bone marrow failure and cancer predisposition. The cellular and molecular pathology of FA is poorly understood, resulting in a severe lack of effective treatment options. In this thesis, I describe the first viable vertebrate model of RAD51 loss. Phenotypic characterisation of zebrafish rad51 loss-of-function mutants showed that they develop key features of FA, including hypocellular kidney marrow, sensitivity to crosslinking agents and decreased size. Taking advantage of the unique properties of the zebrafish model, I show that some of these symptoms stem from both decreased proliferation, as well as increased apoptosis of embryonic haematopoietic stem and progenitor cells. Co-mutation of p$L was able to rescue the haematopoietic defects seen in the single mutants, but led to tumour development, underscoring the role of rad51 as a tumour suppressor. I further demonstrate that prolonged inflammatory stress can exacerbate the haematological impairment, leading to an additional decrease in kidney marrow cell numbers. In contrast, prolonged aldehyde-derived stress did not induce symptoms in the mutant fish. These findings strengthen the assignment of RAD51 as a Fanconi gene and provide more evidence for the notion that aberrant p53 signalling during embryogenesis leads to the haematological defects seen later in life in FA. It also strengthens the evidence for the involvement of haematopoietic stress, such as inflammation, in the development of bone marrow failure. Further research on this novel zebrafish FA model will lead to a deeper understanding of the molecular basis of bone marrow failure in FA and the cellular role of RAD51.
|
10 |
FANCG 637-643 deletion mutation: frequency in black patients with acute myeloid leukaemia or aplastic anaemia and the clinical phenotype of homozygotesHaw, Tabitha 17 November 2006 (has links)
Student Number : 9807768F -
MSc (Med) research report -
Faculty of Health Sciences / Fanconi anaemia (FA) is an autosomal recessive disorder characterised by aplastic anaemia
(AA) and a high risk of developing acute myeloid leukaemia (AML). It is unknown
whether heterozygote carriers are also predisposed to developing these disorders.
The black South African population group is ideal for FA mutation screening because the
presence of a founder mutation, FANCG 637-643, makes screening relatively straight
forward. Three individuals with AML (115 screened) and one with AA (78 screened) were
found to be heterozygous for the black South African founder mutation. From our data it
seems unlikely that this mutation places heterozygous carriers of the mutation at high risk
of developing AML or AA. Three children with AA out of 26 screened, were homozygous
for the mutation. This finding reiterates the importance of screening all children with AA
for FA.
The frequency of certain congenital abnormalities in black South African FA patients was
compared to patients described by other research groups. The frequencies of the
abnormalities were similar to other FANCG cohorts described but significant differences
to a group of FA patients from unspecified complementation groups were found. This
difference could be because different complementation groups are associated more or less
strongly with specific abnormalities.
It was found previously that particular congenital abnormalities in FA patients are
associated with a poor haematological outcome. We concluded that black South African
FANCG patients have a high risk of early development of AA even though they do not
have a high frequency of congenital abnormalities.
|
Page generated in 0.0643 seconds